Option chain shows key data for IM Cannabis's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for IM Cannabis.

IM Cannabis (NASDAQ:IMCC) Stock, Option Chain

IM Cannabis

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

TWIC

Cannabis

Earnings

Government

Regulations

AAWH

AYRWF

CSE:MRMD

GRAM

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

GRUSF

IIPR

IMCC

INNO

INNPF

JSDA

LIEN

MEDIF

MRMD

ROMJF

SHF Holdings, Inc. - Class A Common Stock

SHFS

TLLTF

WEED

This week in cannabis: major mergers, innovative launches, key regulatory updates &amp; leadership changes drive industry transformation.

This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations

elsa-olofsson-12-Zs1xIEtA-unsplash(23)

News

Eurozone

CSE:IMCC

International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported revenue from Germany grew 66% year-over-year, reaching CA$5.8 million ($4.1 million). &#34;While the 66% growth we delivered in Germany, to reach $5.8M this quarter is a highlight, we spent the quarter focused on building a solid foundation for 2025,&#34; Oren Shuster, the company&#39;s CEO, said. &#34;Our goal was to build a strong, consistent supply chain, along with a laser focus on how to improve the efficiency and accuracy of how we use our resources. I believe that the foundation we built this quarter will be the basis we will use to deliver in 2025.&#34;

IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3

pexels-kindelmedia-7668047(1)

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

TSX:WEED

TSX:XLY

Select Sector SPDR-Consumer Discretionary

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will report the second quarter of fiscal year 2025 ended Sept. 30, before financial markets open on Friday, Nov. 8, 2024. IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) a medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third quarter ended Sept. 30 on Nov. 14, 2024, before the market opens. Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) will report earnings results for its third quarter ended Sept. 30 on Friday, Nov. 8, 2024, before the financial markets open.

Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?

IM Cannabis Corp

Press Releases

IM Cannabis Reports Third Quarter Financial Results

Small Cap

IM Cannabis Announces Change of Auditors

IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET

IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results

IM Cannabis Provides Corporate Updates

IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET

IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction

IM Cannabis Reports First Quarter Financial Results

IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange

Comments

IM Cannabis

IM Cannabis (IMCC) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell